Abstract
The development of monoclonal antibodies against malignant cells is projected to have a number of significant applications related to the clinical management of breast cancer. These include the early diagnosis of tumors, monitoring patients for the detection of recurrence or effects of therapy, and therapeutic modalities, whereby antibodies are employed to target cytotoxic agents (drugs, toxins, or radionuclides) to the site of the tumor. Since in Western countries, breast cancer will afflict in the region of one out of every 14 women, it is essential that the potential of these agents should be explored fully. Conventional wisdom indicates that aids to earlier diagnoses would have an important impact on prognosis. Present methods of diagnosis by palpation and mammography permit detection of tumor masses with diameters as small as 1 cm. However, even at this apparently early stage, tumors may be sufficiently established for the dissemination of tumor cells to have already occurred (reviewed by Tagnon, 1986). Thus, if breast cancer is only rarely a localized disease when it is clinically evident, there is clearly a need for assays that might provide earlier, accurate diagnoses and that reflect tumor burden. Given the sensitivity and specificity that can be obtained with monoclonal antibodies, their use in immunoassays offers the possibilities for the measurement of these clinical parameters and for optimizing therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arklie, J., Taylor-Papadimitriou, J., Bodmer, W., Egan, M., and Millis, R., 1981, Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int. J. Cancer 28:23–29.
Ashall, F., Bramwell, M. E., and Harris, H., 1982, A new marker for human cancer cells. 1. The Ca antigen and the Cal antibody. Lancet ii:1–6.
Baldwin, R. W., 1985, Monoclonal antibody targeting of anti-cancer agents: Mühlbock Memorial Lecture. Eur. J. Cancer Clin. Oncol. 11:1281–1285.
Berry, N., Jones, D. B., Smallwood, J., Taylor, I., Kirkham, N., and Taylor-Papadimitriou, J., 1985, The prognostic value of the monoclonal antibodies HMFG-1 and HMFG-2 in breast cancer. Br. J. Cancer 51:179–186.
Bramwell, M. E., Bhavanandan, V. P., Wiseman, G. and Harris, H., 1983, Structure and function of the Cal antigen. Br. J. Cancer 48:177–183.
Bramwell, M. E., Ghosh, A. K., Smith, W. D., Wiseman, S., Spriggs, A., and Harris, H., 1985, Ca2 and Ca3. New monoclonal antibodies as tumor markers in serous effusions. Cancer 56:105–110.
Britton, K. E., Granowska, M., and Shepherd, J., 1985, Localisation of cancer of the ovary and metastases using 123I-labelled monoclonal antibody HMFG-2 compared to surgical findings. In Monoclonal Antibodies for Cancer Detection and Therapy (R. W. Baldwin and V. S. Byers, eds.), pp. 201–221, Academic Press, London.
Burchell, J. M., and Taylor-Papadimitriou, J., 1985, Monoclonal antibodies to breast cancer and their application. In Monoclonal Antibodies for Cancer Detection and Therapy (R. W. Baldwin and V. S. Byers, eds.), pp. 1–15, Academic Press, London.
Burchell, J., Durbin, H., and Taylor-Papadimitriou, J., 1983, Complexity of expression of antigenic determinants recognized by monoclonal antibodies HMFG-I and HMFG-2, in normal and malignant human mammary epithelial cells. J. Immunol. 131:508–513.
Burchell, J., Wang, D., and Taylor-Papadimitriou, J., 1984, Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int. J. Cancer 34:763–768.
Campbell, A. M., McCormack, M. A., Ross, C. A., and Leake, R. E., 1986, Immunological analysis of the specificity of the autologous humoral response in breast cancer patients. Br. J. Cancer 53:7–11.
Canevari, S., Fossati, G., Balsari, A., Sonnino, S., and Colnaghi, M. I., 1983, Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBrl) which specifically binds to human mammary epithelial cells. Cancer Res. 43:1301–1305.
Ceriani, R. L., Thompson, K., Peterson, J. A., and Abraham, S., 1977, Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc. Natl. Acad. Sci. U.S.A. 74:582–586.
Cordell, J., Richardson, T. C, Pulford, K. A. F., Ghosh, A. K., Gatter, K. C, Heyderman, E., and Mason, D. Y., 1985, Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br. J. Cancer 52:347–354.
Corvalan, J. R. F., Axton, C. A., Brandon, D. R., Smith, W., and Woodhouse, C, 1984, Classification of anti-CEA monoclonal antibodies. In Protides of the Biological Fluids (H. Peeters, ed.), Vol. 31, pp. 921–924, Pergamon Press, Oxford.
Dearnaley, D. P., Sloane, J. P., Ormerod, M. G., Steele, K., Coombes, R. C, Clink, H. Mc.D., Powles, T. J., Ford, H. T., Gazet, J.-C, and Neville, A. M., 1981, Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br. J. Cancer 44:85–90.
De Kretser, T., Thome, H. J., Picone, D., and Jose, D. G., 1986, Biochemical characterization of the monoclonal antibody-defined ovarian carcinoma-associated antigen SGA. Int. J. Cancer 37:705–712.
Edwards, D. P., Grzyb, K. T., Dressler, L. G., Mansel, R. E., Zava, D. T., Sledge, G. W., and McGuire, W. L., 1986, Monoclonal antibody identification and characterization of a M r43,000 membrane glycoprotein associated with human breast cancer. Cancer Res. 46:1306–1317.
Edwards, P. A. W., 1985, Heterogeneous expression of cell surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. Br. J. Cancer 51:149–160.
Edwards, P. A. W., and Brooks, I. M., 1984, Antigenic subsets of human breast epithelial cells distinguished by monoclonal antibodies. J. Histochem. Cytochem. 32:531–537.
Ellis, I. O., Robins, R. A., Elston, C. W., Blarney, R. W., Ferry, B., and Baldwin, R. W., 1984, A monoclonal antibody, NCRC-11, raised to human breast carcinoma. I. Production and immunohistological characterization. Histopathology 8:501–506.
Ellis, I. O., Hinton, C. P., MacNay, J., Robins, R. A., Elston, C. W., Owainati, A., Blarney, R. W., Baldwin, R. W., and Ferry, B., 1985, Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC-11—A new prognostic indicator. Br. Med. J. 290:881–883.
Epenetos, A. A., 1984, Antibody guided irradiation of malignant lesions: Three cases illustrating a new method of treatment—A report of the Hammersmith Oncology Group and the Imperial Cancer Research Fund. Lancet i: 1441–1443.
Epenetos, A. A., Britton, K. E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C. C., Durbin, H., Hawkins, L. R., Malpas, J. S., and Bodmer, W., 1982a, Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet ii: 999–1004.
Epenetos, A. A., Canti, G., Taylor-Papadimitriou, J., Curling, ML, and Bodmer, W., 1982b, Use of two epithelium specific monoclonal antibodies for diagnosis of malignancy in serous effusions, Lancet ii: 1004–1006.
Foster, C. S., and Neville, A. M., 1984, Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells, Hum. Pathol. 15:502–513.
Garcia, M., Capony, F., Derocq, D., Simon, D., Pau, B., and Rochefort, H., 1985, Characterization of monoclonal antibodies to the estrogen-regulated A/r52,000 glycoprotein and their use in MCF-7 cells. Cancer Res. 45:709–716.
Gatter, K. C., Alcock, C., Heryet, A., Pulford, K. A., Heyderman, E., Taylor-Papadimitriou, J., Stein, H., and Mason, D., 1984, The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am. J. Clin. Pathol. 82:33–43.
Heyderman, E., Steele, K., and Ormerod, M. G., 1979, A new antigen on the epithelial membrane: Its immunoperoxidase localization in normal and neoplastic tissues. J. Clin. Pathol. 32:35–39.
Heyderman, E., Strudley, I., Powell, G., Richardson, T. C., and Mason, D., 1985, A new monoclonal antibody to epithelial membrane antigen (EMA)—E29. A comparison of its immunocytochemical reactivity with polyclonal antibodies and with another monoclonal antibody, HMFG-2. Br. J. Cancer 52:355–361.
Hilkens, J., Buijs, F., Hilgers, J., Hagemann, Ph., Calafat, J., Sonneberg, A., and Van der Valk, M., 1984, Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int. J. Cancer 34:197–206.
Hilkens, J., Kroezen, V., Buijs, F. Hilgers, J., Van Vleigt, M., De Voogd, W., Bonfrer, J., and Bruning, P. F., 1985, MAM-6, A carcinoma associated marker: Preliminary characterization and detection in sera of breast cancer patients. In Proceedings of the International Workshop on Monoclonal Antibodies and Breast Cancer (R. L. Ceriani, ed.), pp. 28–42, Martinus Nijhoff, Boston.
Hilkens, J., Kroezen, V., Bonfrer, J. M. G., De Jong-Bakker, M., and Bruning, P. F., 1986, MAM-6 antigen, a new serum marker for breast cancer monitoring, Cancer Res. 46:2582–2587.
Janossy, G. J., Thomas, J. A., Pizzolo, G., Granger, S. M., McLaughlin, J., Stansfeld, A. G., and Sloane, J., 1980, Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies, Br. J. Cancer 42:224–242.
Karlsson, S., Swallow, D. M., Griffiths, R., Corney, G., Hopkinson, D. A., Dawney, A., and Carton, J. P., 1983, A genetic polymorphism of a human urinary mucin. Ann. Hum. Genet. 47:263–269.
Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497.
Mastroianni, L., Winternitz, W. W., and Lowi, N. P., 1958, The in vitro metabolism of the human endosalpinx. Fertil. Steril. 9:500–508.
McGee, J. O’D., Woods, J. C., Ashall, F., Bramwell, M. E., and Harris, H., 1982, A new marker for human cancer cells. 2. Immunohistochemical detection of the Ca antigen in human tissues with the Cal antibody. Lancet ii: 7–10.
Mcllhinney, R. A. J., Patel, S., and Gore, M. E., 1985, Monoclonal antibodies recognizing epitopes carried on both glycolipids and glycoproteins of the human milk fat globule membrane, Biochem. J. 227:155–162.
Ménard, S., Tagliabue, E., Canevari, S., Fossati, G., and Colnaghi, M. I., 1983, Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res. 43:1295–1300.
Miotti, S., Aguanno, S., Canevari, S., Diotti, A., Orlandi, R., Sonnino, S., and Colnaghi, M. I., 1985, Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies. Cancer Res. 45:826–832.
Nuti, M., Mottolese, M., Viora, M., Perrone Donnorso, R., Schlom, J., and Natali, P. G., 1986, Use of monoclonal antibodies to human breast tumor associated antigens in fine needle aspirate cytology. Int. J. Cancer 37:493–498.
Ormerod, M. G., Steele, K., Westwood, J. H., and Mazzini, M. N., 1983, Epithelial membrane antigen: Partial purification, assay and properties. Br. J. Cancer 48:533–541.
Ormerod, M. G., Mcllhinney, J., Steele, K., and Shimizu, M., 1985, Glycoprotein PAS-O from the human milk fat globule membrane carries determinants for epithelial membrane antigen. Molec. Immunol. 22:265–269.
Papsidero, L. D., and Johnson, E. A., 1986, Physicochemical purification and immunological characteristics of ductal carcinoma antigen. Int. J. Cancer 37:697–703.
Papsidero, L. D., Croghan, G. A., O’Connel, M. J., Valenzuela, L. A., Nemoto, T., and Ming Chu, T., 1983, Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res. 43:1741–1747.
Pectasides, D., Stewart, S., Courtney-Luck, N., Rampling, R., Munro, A. J., Krausz, T., Dhokia, B., Snook, D., Hooker, G., Durbin, H., Taylor-Papadimitriou, J., Bodmer, W. and Epenetos, A. A., 1986, Antibody-guided irradiation of malignant pleural and pericardial effusions. Br. J. Cancer 53:727–732.
Price, M. R., Brown, A., Armitage, N. C., and Baldwin, R. W., 1985a, Application of a micro-radioimmunoassay to the analysis of monoclonal antibody-defined epitopes on antigen preparations from human colonic cancer. IRCS Med. Sci. 13:366–367.
Price, M. R., Edwards, S., Owainati, A., Bullock, J. E., Ferry, B., Robins, R. A., and Baldwin, R. W., 1985b, Multiple epitopes on a human breast carcinoma associated antigen. Int. J. Cancer 36:567–574.
Price, M. R., Edwards, S., Powell, M., and Baldwin, R. W., 1986a, Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas. Br. J. Cancer 54:393–400.
Price, M. R., Edwards, S., Robins, R. A., Hilgers, J., Hilkens, J., and Baldwin, R. W., 1986b, Epitopes with diagnostic and prognostic significance co-expressed on a human breast carcinoma-associated antigen. Eur. J. Cancer Clin. Oncol. 22:115–117.
Rainsbury, R. M., Westwood, J. H., Coombes, R. C., Neville, A. M., Ott, R. J., Kalirai, T. S., McCready, V. R., and Gazet, J.-C., 1983, Location of metastatic breast carcinoma by monoclonal antibody chelate labelled with indium-111, Lancet ii: 934–939.
Schlom, J., Wunderlich, D., and Teramoto, V. A., 1980, Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 77:6841–6845.
Shimizu, M., and Yamauchi, K., 1982, Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane. J. Biochem. 91:515–524.
Sloane, J. P., and Ormerod, M. G., 1981, Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumour pathology. Cancer 47:1786–1795.
Swallow, D. M., Griffiths, B., Bramwell, M., Wiseman, G., and Burchell, J., 1986, Detection of the urinary “PUM” polymorphism by the tumour binding monoclonal antibodies Cal, Ca2, Ca3, HMFG-1 and HMFG-2, Disease Markers 4:247–254.
Tagnon, H. J., 1986, Some changing concepts of the natural history of human mammary cancer and their effect on diagnosis and treatment. Eur. J. Cancer Clin. Oncol. 22:123–128.
Wilkinson, M. J. S., Howell, A., Harris, M., Taylor-Papadimitriou, J., Swindell, R., and Sellwood, R. A., 1984, The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int. J. Cancer 33:299–304.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Price, M.R. (1988). Breast-Cancer-Associated Antigens Defined by Monoclonal Antibodies. In: Harris, J.R. (eds) Immunological Aspects. Subcellular Biochemistry, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1681-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1681-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1683-9
Online ISBN: 978-1-4899-1681-5
eBook Packages: Springer Book Archive